928
Total Claims
$140K
Drug Cost
207
Beneficiaries
$678
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-52%
Cost per patient vs peers
$678 vs $1,411 avg
+22%
Brand preference vs peers
13.0% vs 10.6% avg
Brand vs Generic
87% generic
Brand: 119 claims · $123K
Generic: 795 claims · $16K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 24 | $40K |
| Evolocumab | 15 | $13K |
| Valsartan/Hydrochlorothiazide | 30 | $1,345 |
| Atorvastatin Calcium | 68 | $977 |
| Valsartan | 31 | $798 |
| Gabapentin | 32 | $790 |
| Diltiazem Hcl | 22 | $535 |
| Rosuvastatin Calcium | 30 | $463 |
| Levothyroxine Sodium | 31 | $416 |
| Tamsulosin Hcl | 12 | $391 |
| Duloxetine Hcl | 15 | $356 |
| Ezetimibe | 16 | $356 |
| Hydralazine Hcl | 17 | $338 |
| Ondansetron | 14 | $236 |
| Metformin Hcl | 14 | $217 |
Prescribing Profile
25
Unique Drugs
$40K
Patient Profile
74
Avg Age
68%
Female
1.05
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About